A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor ...

Select your location to view local American Lung Association events and news near you.

Researchers from Alliance Medical Ltd. performed a retrospective case series review of oncologic FDG PET-CT scans in patients taking GLP-1 agonists ... which prompted a wider review across our network ...

PSMA PET scans significantly enhance detection and staging of prostate cancer, improving patient stratification and survival outcomes. Three FDA-approved PSMA PET scans are available, aiding in both ...

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

Dr George Owiti, a radiographer at Kericho County Hospital examines the Chest CT results of a patient admitted to the hospital. [James Wanzala, Standard] Despite recent breakthroughs that have ...

Researchers have reported that the widespread use of glucagon-like peptide-1 receptor agonists – prescribed for diabetes and ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.

June 30, 2006 (San Diego) — False-positive results on positron emission tomography (PET) with computed tomography (CT) scans, which may suggest that there is a malignancy when in fact there is none, ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...